Feb 8 (Reuters) - Sonnet Biotherapeutics Holdings Inc
SONN.O :
* SONNET BIOTHERAPEUTICS HOLDINGS INC - AS OF DEC 31, 2021,
SONNET
HAD $19.4 MILLION CASH ON HAND
* SONNET BIOTHERAPEUTICS HOLDINGS INC QTRLY LOSS PER SHARE
$0.10
* SONNET BIOTHERAPEUTICS HOLDINGS INC - SON-1010 AND SON-080
ON
TRACK TO INITIATE CLINICAL STUDIES DURING Q2 OF 2022
* SONNET BIOTHERAPEUTICS HOLDINGS INC - CONTINUE TO ADVANCE
PRECLINICAL DEVELOPMENT OF FHAB PIPELINE
Source text for Eikon: ID:
Further company coverage: SONN.O
((Reuters.Briefs@thomsonreuters.com;))